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ABSTRACT
The DNA-binding protein RdgC has been identified
as an inhibitor of RecA-mediated homologous
recombination in Escherichia coli.I nNeisseria
species, RdgC also has a role in virulence-
associated antigenic variation. We have previously
solved the crystal structure of the E. coli RdgC
protein and shown it to form a toroidal dimer. In
this study, we have conducted a mutational
analysis of residues proposed to mediate inter-
actions at the dimer interfaces. We demonstrate
that destabilizing either interface has a serious
effect on in vivo function, even though a stable
complex with circular DNA was still observed. We
conclude that tight binding is required for inhibition
of RecA activity. We also investigated the role of the
RdgC finger domain, and demonstrate that it plays a
crucial role in the binding of circular DNA. Together,
these data allow us to propose a model for how
RdgC loads onto DNA. We discuss how RdgC
might inhibit RecA-mediated strand exchange, and
how RdgC might be displaced by other DNA metab-
olism enzymes such as polymerases and helicases.
INTRODUCTION
The rdgC gene encodes a 34-kDa nucleoid-associated
protein (1), which was originally identiﬁed as a factor es-
sential for growth in recombination-deﬁcient mutants of
Escherichia coli (2). More recent studies show it to be
required for viability in strains lacking the primosome
assembly protein, PriA, and to counter
RecFOR-mediated loading of RecA (3). Biochemical
studies revealed that RdgC binds non-speciﬁcally to
linear and circular DNA (3,4), and inhibits RecA-
mediated strand exchange reactions in vitro (5). Taken
together, these data are consistent with the proposed
cellular function of RdgC as a modulator of RecA
activity.
RecA is essential for homologous recombination in pro-
karyotes, which provides a generally error-free pathway
for the repair of DNA double-strand breaks and for the
rescue of damaged replication forks. RecA, and the
archaeal and eukaryotic homologues RadA and Rad51
respectively, catalyse the key process of homologous
DNA strand exchange (6,7). RecA assembles on ssDNA
to form a helical ﬁlament which repeatedly binds non-
speciﬁcally to dsDNA, searching for a region of
homology. Once a homologous region is found, RecA
promotes switching of base pairs between the unwound
duplex and the RecA-coated ssDNA. The resulting
heteroduplex intermediates can then be processed by a
variety of pathways resulting in a repaired break or a
rescued replication fork.
Homologous recombination also promotes the biologic-
al ﬁtness of a species by increasing population genetic
variation (8). For example, Neisseria gonorrhoeae (9) and
Neisseria meningitidis (10) use a RecA-mediated recombin-
ation process to alter the sequence of the main structural
component of the type IV pili. It is thought that the high
rate of pilin antigenic variation contributes to evasion of
the host immune response, explaining the failure of
pilus-based vaccine trials (11). Interestingly, RdgC has
been shown to promote recombination-dependent anti-
genic variation in Neisseria sp. (12). RecA-mediated
homologous recombination is also thought to be
involved in antigenic variation and virulence in other
prokaryotic pathogens, such as Helicobacter pylori (13),
Campylobacter fetus (14), Pseudomonas tolaasii (15) and
Haemophilus inﬂuenzae (16), while Rad51-mediated
homologous recombination is thought to play an equiva-
lent role in the eukaryotic parasite, Trypanosoma
brucei (17).
Since recombination plays such an important part in
DNA repair and genome maintenance, it is essential to
control where, when and how recombination occurs.
When unregulated, recombination can lead to genome in-
stability and carcinogenesis. The RecA family of recom-
binases provide an obvious target for regulation (18,19).
In E. coli, RecA function is regulated at many levels (18).
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SOS response, which provides the ﬁrst level of regulation.
RecA itself provides another level of control, as the
C-terminal region has been shown to have an
autoregulatory function. Additionally, many other
proteins have been shown to modulate RecA activity.
The SSB protein competes with RecA for ssDNA, and
can block RecA ﬁlament formation if it binds to ssDNA
before the addition of RecA. However, SSB can also
remove secondary structure from ssDNA, so promoting
the formation of the RecA ﬁlament. The RecF, RecO and
RecR proteins have been shown to provoke both the
assembly and disassembly of RecA ﬁlaments, and to be
necessary for the loading of RecA onto SSB-coated DNA.
RecBCD actively loads RecA onto the regions of ssDNA
it creates as it resects a DNA end. The DinI and RecX
proteins are antagonists, acting to either stabilize or de-
stabilize RecA ﬁlaments, respectively. The PsiB protein
inhibits nucleoﬁlament assembly by binding free RecA,
blocking the site necessary for SSB displacement as well
as reducing DNA-binding aﬃnity (20). RdgC is another
protein that modulates homologous recombination, acting
as a negative regulator of RecA activity.
In order to better understand how RdgC could inhibit
RecA activity, we determined the crystal structure of
RdgC from E. coli (21). This structure shows RdgC to
form a dimeric ring or toroid, with a head-to-head,
tail-to-tail organization (Figure 1A). Electropositive
‘ﬁnger’ domains project on either side of the ring face
(Figure 1B). The 30A ˚ diameter hole at the centre of the
ring is lined with positively charged residues and provides
the likely site for DNA binding. A similar structure was
seen for RdgC from Pseudomonas aeruginosa (22).
Although advantageous for a protein that binds to and/
or moves along DNA (23), a toroidal shape poses a
problem when binding circular DNA, as this requires
the ring to open.
Other toroidal proteins, e.g. the b-clamp (24) and
PCNA (25) sliding clamp processivity factors and the
DnaB (26) and BLM (27) hexameric helicases, achieve
ring-opening with the assistance of accessory proteins.
The sliding clamps are assembled on DNA by clamp
loader proteins in an ATP-dependent reaction (28),
while some hexameric helicases have accessory proteins
necessary for eﬃcient DNA binding. In E. coli, the
DnaC protein facilitates assembly of the replicative
helicase, DnaB, on DNA (29). Likewise, the Cdc6
protein is implicated in the loading of the eukaryotic rep-
licative MCM helicase complex (30). However, accessory
proteins are not required in all cases; the T7 gp4A’ repli-
cative helicase has an additional N-terminal primase
domain which provides the DNA loading activity (31).
Our studies, reported here, conﬁrm that RdgC can also
load onto circular DNA without the requirement for ac-
cessory proteins, and we provide evidence that the ‘ﬁnger’
domains provide the required DNA-loading activity. We
propose a model explaining how the ﬁnger domain opens
the RdgC ring, allowing it to load onto circular DNA. We
also identify residues at the domain interfaces that are
necessary for forming a stable RdgC-DNA complex
in vitro, and demonstrate that the in vivo function of
RdgC is dependent on the ability to form a stable
tight-binding protein–DNA complex. This provides an
insight into the mechanism of how RdgC could
modulate RecA-mediated recombination.
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Figure 1. Structure of RdgC. (PDB co-ordinates 2OWL). (A) A ribbon
diagram showing the ring structure of RdgC and identifying the horse-
shoe and gate regions. The dotted line indicates the horseshoe domain
interface. (B) A rotated ribbon diagram illustrating projection of the
ﬁnger domains. The dotted line indicates the gate domain interface. (C)
Detail of one of the hydrogen bond networks at the horseshoe interface
between the Q212 and E218 residues on one dimer and K227 on the
other. The conserved H222 residues are also shown. (D) Detail of the
gate interface interactions, showing the conserved F120 residues and
the modelled disulphide formed in the R118C derivative.
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Bacterial strains and plasmids
Mutant rdgC genes encoding RdgC with speciﬁc substitu-
tions and deletions were made by site-directed mutagen-
esis using either the Quikchange (Stratagene) or the
Phusion (Finnzymes) mutagenesis procedures. All
plasmid constructs (Table 1) were based on the pT7-7
derivative containing the rdgC gene, pGS583 (3) or the
pET22b derivative, pYJ001, containing the NdeI–
HindIII rdgC gene fragment from pGS583. All mutations
were conﬁrmed by DNA sequencing.
All strains used for the synthetic lethality assay
(Table 2) are derivatives of E. coli MG1655 lacIZYA,
TB28 (32) carrying a priA
+ derivative of pRC7, pAM374
(33). A cat expression cassette was placed immediately
downstream of either native or mutant rdgC in the
pET22b-derivative expression plasmid. The rdgC-cat
cassette was used to replace the native rdgC from the
start to the stop codon in TB28 by chromosome engineer-
ing (34) and conﬁrmed by sequencing. These mutations
were combined with either priA or priA dnaC810 by
P1 transduction to the appropriate recipient (35).
Synthetic lethality assays were performed as described pre-
viously (33), using either LB media (LB) or 56/2 minimal
media (MA) (35). The MG1655 recA strain, N7358, was
constructed by replacing the recA gene (deleting residues
G16 to S330) with a spectinomycin resistance cassette by
chromosome engineering.
Expression and puriﬁcation of RdgC
Native RdgC was expressed from E. coli BL21(DE3)
pLysS containing pGS583 as described previously (3).
Mutant RdgC proteins were expressed in YJ014, a
rdgC::dhfr version of BL21(DE3) pLysS, containing
the relevant pT7-7 or pET22b derivative of rdgC,a s
described for native RdgC. Native and mutant RdgC
proteins were puriﬁed using an identical protocol as
described previously (21). Induced cells from 1l of
culture were resuspended in buﬀer A (50mM Tris–HCl,
pH 7.5, 1mM EDTA, 1mM DTT), lysed by sonication on
ice, and cell debris was removed by centrifugation. RdgC
was recovered from the supernatant by 40–65%
ammonium sulphate precipitation and the pellet was re-
suspended in buﬀer A containing 0.2M NaCl. This was
puriﬁed by passage through a 5ml Hitrap Heparin HP
column (GE Healthcare), a 5ml Hitrap Q-sepharose HP
column (GE Healthcare) and a HiPrep 16/60 Sephacryl
S200 HR gel ﬁltration column (GE Healthcare).
Fractions containing pure RdgC were dialysed against
buﬀer A containing 150mM NaCl and 50% glycerol
before storage at  80 C. A Superdex 75 10/300 GL
column (GE Healthcare) was used for analytical gel ﬁltra-
tion, where a 100ml sample of 10mM RdgC (dimer con-
centration) was eluted in gel ﬁltration buﬀer (50mM Tris,
pH 7.5, 100mM NaCl) at 0.5ml/min. All chromatography
steps where performed at 4 C.
Oligonucleotide and plasmid binding assays
The ssDNA substrate was made by labelling the oligo-
nucleotide RGL13 (50-GAC GCT GCC GAA TTC
TGG CTT GCT AGG ACA TCT TTG CCC ACG
TTG ACC C-30) at the 50-end with [a
32P] ATP using T4
polynucleotide kinase (New England Biolabs).
Unincorporated ATP was removed using a Biospin P6
spin column (Biorad).The 49-bp duplex substrate,
RGL13/17, was made by annealing labelled RGL13 to
RGL17 (50-GGG TCA ACG TGG GCA AAG ATG
TCC TAG CAA GCC AGA ATT CGG CAG CGT
C-30). The duplex was puriﬁed by gel electrophoresis and
eluted into 10mM Tris–HCl, pH 8.5.
Binding of RdgC to either RGL13 or RGL13/17 was
measured using a band-shift assay, as described previously
(36). Brieﬂy, RdgC and
32P-labelled substrate DNA were
mixed in binding buﬀer [50mM Tris–HCl, pH 8.0, 5mM
EDTA, 1mM DTT, 100mg/ml BSA, 6% (v/v) glycerol]
and incubated on ice for 15min before electrophoresis at
160V on a prechilled 4% native polyacrylamide gel in low
ionic strength buﬀer (6.7mM Tris–HCl, pH 8.0, 3.3mM
sodium acetate, 2mM EDTA). Binding was quantiﬁed by
calculating the amount of free (unbound) oligonucleotide
using the software package ImageJ (37). Apparent dissoci-
ation constants were calculated as described previously
(38) using the curve-ﬁtting module in the software
package Prism (GraphPad Software). Band-shift assays
with plasmid DNA were performed using circular
pGEM-7 Zf(+) plasmid prepared using a Qiaprep spin
column (Qiagen). Plasmid and protein were mixed and
incubated using the same conditions as for oligonucleotide
band-shift assays before loading onto a 1% agarose gel.
After electrophoresis at 80V for 90min, gels were stained
with SYBR Green (Molecular Probes) and visualized
under UV light.
RESULTS
"priA strains can be used to measure rdgC function
To characterize the eﬀects of mutations on the RdgC
protein, we needed an assay for in vivo function.
Previous studies have revealed that a priA rdgC
Table 1. Plasmid constructs used
Amino acid Substitution pT7-7
derivative
pET22b
derivative
pET22b-cat
derivative
Wild-type pGS583 pYJ001 pAM447
R118A pGB049 pGB050 pAM450
R118C pGB045 pGB047 pAM441
F120S pGB051 pGB052 pAM465
F120T pGB053 pGB054 pAM466
R118C, F120T pGB065 pYJ019
Q212A pYJ017 pYJ020
E218R pYJ013 pAM448
H222A pYJ003 pYJ006 pAM443
K227A pYJ007 pAM444
F120T, K227A pGB084
ﬁnger (P76G, 77–115, L116T) pGB043 pAM434 pAM437
ﬁnger, R118C pGB046 pGB048 pAM442
Fingertip
(R97S, K98Q, K100Q, K101E)
pGB055 pGB056 pAM468
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(3). The poor viability of priA mutants, and how this can
be suppressed by mutations in dnaC such as dnaC810,
dnaC212 and dnaC809,820 is well documented (40–42),
and the introduction of dnaC212 to a priA rdgC
strain partly recovers viability, resulting in a slow-growth
phenotype (3). We established a synthetic lethality assay
(32) to study the eﬀect of rdgC mutations in priA
and priA dnaC810 backgrounds. The assay is based
on a pRC7, a lac
+ mini-F derivative that is rapidly
lost. The loss of the plasmid is revealed in lac strains
by the appearance of white or sectored colonies on
Table 2. Escherichia coli strains used
Strain Relevant genotype Source or reference
N3072 W3110 recA269::Tn10 (2)
DIM167 DM4000 priA2::kan dnaC810 zji-202::Tn10 (3)
YJ014 BL21 (DE3) plysS DrdgC::dhfr This work
MG1655 derivatives
MG1655 (44)
PN105 priA2::kan sulA (45)
N5521 priA300 dnaC810 zji-202::Tn10 P1 DIM167   N5500 to Tc
r
N5539 priA2::kan dnaC810 zji-202::Tn10 P1 PN105   N5521 to Km
r
N4586 DrdgC::dhfr (3)
N7358 DrecA::spc This work
TB28 DlacIZYA (32)
TB28 derivatives
AM1833 rdgCR118C-cat This work
AM1834 rdgCP76G,D(77-115),L116T-cat This work
AM1835 rdgCP76G,D(77-115),L116T,R118C-cat This work
AM1836 rdgCH222A-cat This work
AM1837 rdgCK227A-cat This work
AM1838 rdgCR118A-cat This work
AM1840 rdgCE218R-cat This work
AM1887 rdgCwt-cat This work
AM1905 rdgCF120T-cat This work
AM1917 rdgCF120S-cat This work
AM1929 DrdgC2::dhfr This work
AM1950 rdgCR97S,K98Q,K100Q,K101E-cat This work
AM2029 rdgCQ212A-cat This work
YJ025 rdgCR118C,F120T-cat This work
TB28 derivatives containing pAM374 (pRC7-priA
+)
N5936 (33)
N5972 DpriA::apra (33)
N6021 DpriA::apra dnaC810 zji-202::Tn10 P1 N5539   N5972 to Tc
r
N6038 DrdgC::dhfr P1 N4586   N5936 to Tm
r
N6040 DpriA::apra DrdgC::dhfr P1 N4586   N5972 to Tm
r
N6111 DpriA::apra dnaC810 zji-202::Tn10 DrdgC::dhfr P1 N4586   N6021 to Tm
r
N7701 DpriA::apra dnaC810 zji-202::Tn10 DrdgC::dhfr DrecA::spc P1 N7358   N6111 to Sp
r
N7709 DpriA::apra DrdgC::dhfr recA269::Tn10 P1 N3072   N6040 to Tc
r
AM1853 DpriA::apra dnaC810 zji-202::Tn10 rdgCR118C-cat P1 AM1833   N6021 to Cm
r
AM1854 DpriA::apra dnaC810 zji-202::Tn10 P1 AM1834   N6021 to Cm
r
rdgCP76G,D(77-115),L116T-cat
AM1855 DpriA::apra dnaC810 zji-202::Tn10 P1 AM1835   N6021 to Cm
r
rdgCP76G,D(77-115),L116T,R118C-cat
AM1856 DpriA::apra dnaC810 zji-202::Tn10 rdgCH222A-cat P1 AM1836   N6021 to Cm
r
AM1857 DpriA::apra dnaC810 zji-202::Tn10 rdgCK227A-cat P1 AM1837   N6021 to Cm
r
AM1858 DpriA::apra dnaC810 zji-202::Tn10 rdgCR118A-cat P1 AM1838   N6021 to Cm
r
AM1860 DpriA::apra dnaC810 zji-202::Tn10 rdgCE218R-cat P1 AM1840   N6021 to Cm
r
AM1911 DpriA::apra rdgCF120T-cat P1 AM1905   N5972 to Cm
r
AM1912 DpriA::apra dnaC810 zji-202::Tn10 rdgCF120T-cat P1 AM1905   N6021 to Cm
r
AM1918 DpriA::apra DrdgC2::dhfr P1 AM1929   N5972 to Tm
r
AM1919 DpriA::apra dnaC810 zji-202::Tn10 DrdgC2::dhfr P1 AM1929   N6021 to Tm
r
AM1948 DpriA::apra rdgCR97S,K98Q,K100Q,K101E-cat P1 AM1950   AM1918 to Cm
r
AM1949 DpriA::apra dnaC810 zji-202::Tn10 rdgCR97S,K98Q,K100Q,K101E-cat P1 AM1950   AM1919 to Cm
r
AM1963 DpriA::apra rdgCF120S-cat P1 AM1917   AM1918 to Cm
r
AM1964 DpriA::apra dnaC810 zji-202::Tn10 rdgCF120S-cat P1 AM1917   AM1919 to Cm
r
YJ041 DpriA::apra rdgCQ212A-cat P1 AM2029   AM1918 to Cm
r
YJ043 DpriA::apra rdgCR118C,F120T-cat P1 YJ025   AM1918 to Cm
r
YJ044 DpriA::apra dnaC810 zji-202::Tn10 rdgCQ212A-cat P1 AM2029   AM1919 to Cm
r
YJ046 DpriA::apra dnaC810 zji-202::Tn10 rdgCR118C,F120T-cat P1 YJ025   AM1919 to Cm
r
YJ047 DpriA::apra rdgCwt-cat P1 AM1887   AM1918 to Cm
r
YJ048 DpriA::apra dnaC810 zji-202::Tn10 rdgCwt-cat P1 AM1887   AM1919 to Cm
r
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By using a derivative of the plasmid that contains the
priA
+ gene to cover a chromosomal deletion of priA
(priA
+/priA), the viability of cells containing priA in
combination with mutations in dnaC and rdgC can be
determined, and so provide a measure of in vivo RdgC
activity.
When a priA (rdgC
+) strain of E. coli containing the
priA
+derivative of pRC7 is grown on LB agar plates con-
taining X-gal and IPTG, two colony types can be
observed: large blue colonies formed by cells retaining
the priA
+ plasmid and small white colonies formed by
cells that have lost the plasmid and therefore are priA
 
(Figure 2ii). Certain mutations in dnaC suppress this
poor-growth phenotype, and a priA
+/priA dnaC810
strain gives large white colonies and sectored blue
colonies, demonstrating the suppression of priA by
dnaC810 (Figure 2iii). When rdgC is introduced into a
priA
+/priA strain, only blue colonies are seen when
grown on LB agar (Figure 2v). Slow growth conditions,
such as growth on minimal media, is known to promote
viability of priA mutants (43), but growth of
priA
+/priA rdgC on 56/2 minimal agar (MA) yielded
only blue colonies (Figure 2viii), demonstrating that priA
is essential for viability in a rdgC background. A
priA
+/priA dnaC810 rdgC strain also yielded blue
colonies on LB agar, with no white colonies
(Figure 2vi). However, it segregates white colonies on
MA (Figure 2ix), indicating that RdgC is dispensable
under these conditions. Viability could also be recovered
in a priA dnaC810 rdgC strain by eliminating
recA (Figure 2vii), enabling robust growth on LB
agar and providing strong evidence that the in vivo
function of RdgC is to modulate RecA activity. The use
of the synthetic lethality assay, as described here, provides
us with a method for measuring in vivo RdgC
functionality.
The design of mutations to destabilize dimer interfaces
Previous analysis of the RdgC crystal structure identiﬁed
six residues as targets for mutation studies (21). Conserved
residues Q212 and E218 are positioned at one end of the
a6-helix, with a conserved K227 residue at the other.
When opposing a6-helices come together at the ‘horse-
shoe’ domain boundary, these residues form two sets of
hydrogen bond networks across the horseshoe dimer inter-
face (Figure 1A and C). We attempted to disrupt this
network with Q212A, E218R and K227A substitutions.
A conserved residue H222 is positioned in the middle of
these a6-helices, and may also be important for the stabil-
ity of the interface. This was investigated by a H222A
substitution. The ‘gate’ interface (Figure 1B) appears to
be stabilized by hydrogen bonding between opposing
R118 residues, and by the interactions between F120
and a hydrophobic pocket on the opposing monomers.
We examined the importance of these with R118A,
F120S and F120T substitutions. We also looked at the
eﬀect of increasing the stability of the gate interface by
an R118C substitution, both in isolation and in combin-
ation with an F120T mutation, as modelling studies using
DSDBASE (39) had suggested that opposing R118C
residues could form a disulphide bond across the dimer
interface (Figure 1D).
Figure 2. The eﬀect of rdgC on the viability of priA and priA dnaC810 strains. Photographs of plates illustrating the results of synthetic
lethality assays. All constructs contained a priA
+ derivative of the pRC7 plasmid, and white colonies indicate the segregation of plasmid-free cells.
Cells were plated on either LB agar (rich medium) or MA (56/2 minimal agar medium) as indicated.
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In addition to looking at the in vivo eﬀects of mutations at
the dimer interfaces, we also wanted to investigate the
in vitro activities of the puriﬁed proteins, to compare
and correlate with the synthetic lethality data. RdgC
binds tightly to small oligonucleotides, with a slight pref-
erence for dsDNA over ssDNA (3). We puriﬁed each of
our mutant RdgC proteins so that we could look at the
DNA binding activity. All behaved identically to the
wild-type protein throughout the puriﬁcation procedure,
and both the wild-type protein and the mutants eluting as
a single peak during gel ﬁltration with an estimated size of
 60kDa. This agrees with previous work reporting that
RdgC elutes as a dimer by gel ﬁltration (3,5), as the
calculated molecular weight of the RdgC monomer is
34kDa. However, more detailed analysis showed the
emergence of a secondary peak or shoulder, correspond-
ing to a larger protein species with an estimated size of
 120kDa, after incubation of RdgC samples in gel ﬁltra-
tion buﬀer (50mM Tris, pH 7.5, 100mM NaCl) at both
room temperature and at 4 C (Figure 3A and B and data
not shown). This secondary peak was particularly
pronounced in mutants containing the R118C mutation,
indicating disulphide-bound RdgC oligomers (Figure 3C).
The addition of 5mM DTT to this disulphide-bound
species resulted in a loss of the secondary peak and an
equivalent increase in the main peak. These results
indicate that, due to its non-compact structure, monomer-
ic RdgC elutes at the position of a 60kDa protein,
whereas the dimer elutes as a 120kDa protein. These
results also suggest that RdgC was monomeric when
puriﬁed, and the secondary peak is evidence of the
protein dimerizing after puriﬁcation. The puriﬁcation pro-
cedure contains several steps that involve exposure to
highly ionic conditions (ammonium sulphate precipita-
tion, elution from heparin and Q-sepharose columns at
high NaCl concentration) which could aﬀect the inter-
actions at the dimer interfaces. Gel ﬁltration analysis of
pre-incubated RdgC in either 1M NaCl or after
ammonium sulphate precipitation conﬁrmed the loss of
the secondary peak consistent with the dimeric protein
becoming monomeric (data not shown); suggesting the
monomeric state of puriﬁed RdgC may be an artefact of
the puriﬁcation procedure. CD analysis demonstrated that
the mutant proteins contained similar proportions of sec-
ondary structure as the native protein (data not shown).
From this, we concluded that all of our mutants had
folded correctly and had broadly equivalent structures
and characteristics to that of the native protein.
Consequently, we could investigate the eﬀect of substitu-
tions at the dimer interfaces using in vitro DNA binding
studies.
A stable dimer interface is essential for in vivo and
in vitro RdgC activity
We performed band-shift assays with RdgC and either
49-bp dsDNA oligonucleotide, RGL13/17, (Figure 4A
and B) or a 49-nt ssDNA oligonucleotide, RGL13,
(Figure 4C). Native RdgC gave multiple bands with the
49-bp dsDNA oligonucleotide at high protein concentra-
tions, suggesting two or more molecules of the RdgC
dimer were able to bind to each oligonucleotide.
Previous studies have also described the formation of
higher-order complexes (3–5), and analysis of the crystal
structure suggests that a single dimer of RdgC could
interact with  15–20bp (21), so the higher order
complexes would be consistent with a 49-bp oligonucleo-
tide containing 2–3 binding sites. To account for the
presence of multiple bands, we quantiﬁed the reduction
in intensity of the band correlating to the unbound oligo-
nucleotide rather than those associated with the formation
of protein-oligonucleotide complexes. Analysis of the re-
sulting binding curves, assuming that the concentration of
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Figure 3. Analytical gel ﬁltration analysis of RdgC proteins. (A) Gel
ﬁltration of puriﬁed WT RdgC protein. Protein was diluted to a ﬁnal
concentration of 10mM (dimer) in gel ﬁltration buﬀer and either
analysed immediately or incubated overnight at 4 C before analysis
on a Superdex 75 10/300 column (GE Healthcare). (B) Gel ﬁltration
of puriﬁed RdgC proteins. Protein was diluted to a ﬁnal concentration
of 10mM (dimer) in gel ﬁltration buﬀer and incubated overnight at 4 C
before analysis on a Superdex 75 10/300 column (GE Healthcare). (C)
Gel ﬁltration of puriﬁed RdgC R118C F120T protein. Protein was
diluted to a ﬁnal concentration of 10mM (dimer) in gel ﬁltration
buﬀer and either analysed immediately or incubated overnight at 4 C
before analysis on a Superdex 75 10/300 column (GE Healthcare). An
additional sample was incubated and analysed in gel ﬁltration buﬀer
containing 5mM DTT. (D) Gel ﬁltration of puriﬁed RdgC ﬁnger
proteins. Proteins were diluted to a ﬁnal concentration of 10mM
(dimer) in gel ﬁltration buﬀer and incubated overnight at 4 C before
analysis on a Superdex 75 10/300 column (GE Healthcare). An add-
itional sample of ﬁnger R118C was incubated and analysed in gel
ﬁltration buﬀer containing 5mM DTT.
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sociation constant (Kd), can provide a measure of binding
aﬃnity by the calculation of approximate Kd values (38).
These were estimated as 7nM for the RdgC dimer when
bound to dsDNA and 9nM when bound to ssDNA.
Pre-incubation of RdgC, to change the proportions of
primary and secondary forms as observed by gel ﬁltration,
had no eﬀect on the binding properties of RdgC (data not
shown). Band-shift assays using our mutant proteins
showed that the DNA binding of proteins with either a
R118A or R118C substitution at the gate interface was
largely indistinguishable to that of the native protein
(Figure 4B and C), and analysis of binding curves gave
calculated Kd values of 6nM for both proteins for both
ssDNA and dsDNA. Surprisingly, synthetic lethality
assays, where the chromosomal copy of rdgC is replaced
with mutated copies, revealed that the R118A and R118C
mutations (Figure 5 and data not shown) did have a weak
eﬀect on functionality. Only blue colonies appear when
combined with priA
+/priA on LB agar, although we
see large white and sectored colonies in a priA
+/priA
dnaC810 background, or when cells are plated on MA.
However, as this eﬀect was relatively mild, and in conjunc-
tion with the DNA binding data, this implies the
hydrogen-bond network between opposing R118
residues at the gate interface is not important for dimer
stability. Additionally, the R118C disulphide bond, if
formed in vivo, does not seriously inhibit or promote
function.
Similar results were seen with the H222A substitution at
the horseshoe interface. Binding to both ssDNA and
dsDNA was largely indistinguishable to that of the
wild-type protein (Figure 4B and C), with estimated Kd
values of 5nM for ssDNA and 12nM for dsDNA.
Synthetic lethality assays showed this mutation was
slightly more deleterious than the R118 mutations
(Figure 5), as the white colonies observed in a priA
+/
priA dnaC810 background, or when plated on MA in
a priA
+/priA background, were signiﬁcantly smaller
than those observed for R118A or R118C. However, the
cells were viable after the loss of the priA
+ plasmid, sug-
gesting H222 is not a major factor in stabilizing the horse-
shoe dimer interface.
In contrast, strains containing derivatives of RdgC with
Q212A, E218R or K227A mutations at the horseshoe
interface, or with F120S or F120T mutations at the gate
interface all gave only blue colonies in both the priA
+/
priA and priA
+/priA dnaC810 backgrounds when
grown on LB agar (Figure 5 and data not shown). In
addition, growth on MA could not recover viability in
the priA
+/priA background. This suggested that each
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Figure 4. Oligonucleotide binding by RdgC proteins. (A)
Representative band-shift assays with dsDNA. Reactions used the
RdgC proteins indicated at 0, 0.375, 0.75, 1.5, 3, 6, 12, 24 and
1850nM (of dimer) and
32P-labelled RGL13/17 DNA at 0.2nM.
Assays with R118A, R118C, Q212A and H222A gave the same band
pattern as the WT protein. Assays with F120S and K227A gave the
same band pattern as F120T. (B) Quantiﬁcation of dsDNA binding.
RGL13/17 DNA was used at 0.2nM. Data are means of at least two
band-shift experiments. (C) Quantiﬁcation of ssDNA binding.
32P-labelled RGL13 DNA was used at 0.2nM. Data are means of at
least two band-shift experiments. (D) Eﬀect of DTT on duplex binding
by RdgC R118C F120T. Reactions used mutant RdgC protein at 0, 1,
5, 25, 125 and 625nM (of dimer) and
32P-labelled RGL13/17 DNA at
0.2nM. (E) Plasmid binding by RdgC proteins. Reactions used the
RdgC proteins indicated at 0, 34, 68, 136, 272, 544, 1088, 2176 and
23400nM (of dimer) and pGEM-7 Zf(+) circular dsDNA at 2.2nM
plasmid (6480nM nucleotide pairs). (F) Plasmid binding by the F120T
K227A double mutant. Reactions used mutant RdgC at 0, 1000, 2000,
5000, 10000 and 20000nM (of dimer) and pGEM-7 Zf(+) circular
dsDNA at 2.2nM plasmid (6480nM nucleotide pairs).
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formed stabilizing interactions across the dimer interfaces.
However, interpretation of the in vitro binding data shows
that the situation is more complex. DNA binding by the
K227A, F120T and F120S mutants is particularly poor
(Figure 4A–C), which agrees well with the results of the
synthetic lethality assays. All have estimated Kd values of
between 100 and 500nM with dsDNA and 500–1500nM
with ssDNA. In these cases, it is impossible to get an
accurate Kd value as the complex is evidently falling
apart as it undergoes electrophoresis, as indicated by the
broadening and smearing of bands observed on the gels
(Figure 4A). Even at high concentrations of protein
(>1mM), we did not see 100% binding. These data
suggest that disruption of the domain interfaces has a
severe eﬀect on the ability of RdgC to stably bind DNA,
and that binding of ssDNA is aﬀected more than the
binding of dsDNA.
The juxtaposition of binding dsDNA with binding
ssDNA is clearly shown with the E218R mutant.
Binding to ssDNA is extremely weak (Figure 4C), of the
same order as that of K227A, F120S and F120T.
However, it appears to bind dsDNA reasonably well
(with an estimated Kd of 22nM), although this is still
weaker than the native protein, and the smearing
observed on the gel indicates the complex is dissociating
during electrophoresis (Figure 4A and B). The Q212A
mutant is even more surprising, as both ssDNA and
dsDNA binding appeared to be equivalent to the native
protein, with estimated Kds of between 5 and 15nM. This
is at odds with the in vivo data, and implies that RdgC
functionality reﬂects more than just the ability to bind
short oligonucleotide DNA. The diﬀerences between
DNA binding by the E218R and Q212A proteins may
also suggest that the cross-domain interaction between
K227 and E218 at the horseshoe interface is more import-
ant to domain stability than that between K227 and Q212.
Overall, these data may help to explain the diﬀerences in
binding of dsDNA and ssDNA observed for many of the
mutants and for the native protein. Binding dsDNA in the
central pore allows interactions between the protein and
the DNA across the whole surface of the pore, which may
assist in pulling and holding the domain together, meaning
the cross-interface interactions becomes less important.
Because ssDNA is unlikely to interact with all the
residues lining the central pore, it is less likely to pull
the domains together and so the stability of the dimer
becomes more dependent on the interactions at the
domain interfaces.
To check whether a R118C disulphide could substitute
for the F120 hydrophobic interaction at the gate dimer
interface, we combined these two mutations to form an
R118C F120T double mutant. Synthetic lethality assays
indicated that the viability of this double mutant was iden-
tical to that of the F120T single mutant in both the priA
+/
priA and priA
+/priA dnaC810 backgrounds, suggesting
either that the disulphide bond does not form in vivo,o r
that it cannot compensate for the F120 hydrophobic inter-
action. However, the analytical gel ﬁltration data suggests
that the R118C disulphide bond is present in vitro and the
DNA binding data suggests it can partially overcome the
loss of the F120-mediated interaction. Improved binding
of both dsDNA and ssDNA is observed when comparing
the double mutant with the F120T single mutant
(Figure 4A–C), with the estimated Kd values changing
from >500nM to <20nM. Additionally, no band
smearing or broadening (attributable to complex dissoci-
ation) was observed, and the formation of multiple bands
associated with higher order complex formation was com-
parable to that for the native protein. To conﬁrm whether
the increased stability was due to the formation of a
R118C-mediated disulphide bond, we repeated the
binding experiments in binding buﬀer containing either
no DTT, or 5mM DTT (Figure 4D). This clearly
demonstrated that the increased stability of the R118C
F120T double mutant relative to the F120T single
mutant is sensitive to DTT and so is due to the formation
of a disulphide bond. This suggests that either the
recovery of in vitro DNA binding activity is not enough
to recover in vivo viability or the disulphide bond does not
form in vivo.
As F120 appeared to be the key residue at the gate
interface and K227 appeared to be the key residue at the
horseshoe interface, we constructed an F120T K227A
double mutant to determine the eﬀect of weakening both
interfaces simultaneously with the expectation that this
protein would not be able to dimerize. As with the single
mutant derivatives, the double mutant puriﬁed using the
same methodology as the wild-type RdgC, although it
eluted from the Heparin-HP column at signiﬁcantly
lower NaCl concentrations than wild-type RdgC or any
Figure 5. The eﬀect of rdgC mutations on the viability of priA and
priA dnaC810 strains. Photographs of plates illustrating the results of
synthetic lethality assays. All constructs contained a priA
+ derivative
of the pRC7 plasmid, and white colonies indicate the segregation of
plasmid-free cells. Colonies were grown on either LB agar or MA as
indicated.
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demonstrated that it eluted in the same volume as the
wild-type protein, with an estimated molecular weight of
60kDa. However, the secondary peak, with estimated
MW of 120kDa, was not seen after incubation at room
temperature or at 4 C. This would suggest that combining
the F120T and the K227A mutations was successful in
limiting the ability of RdgC to dimerize.
As expected, dsDNA binding by the F120T K227A
double mutant was very poor, and far weaker than that
observed for either the F120T or the K227A single mutant
(Figure 4B). Signiﬁcant smearing was observed on the
band-shift gels, indicative of complex dissociation, and
the very weak binding meant it was impossible to calculate
a Kd value. More surprising was the complete lack of
binding seen with ssDNA (Figure 4C), with no complex
formation observed even at a 5000-fold excess of protein
over oligonucleotide. These results are consistent with the
double mutant being a monomer in solution, and the weak
binding observed with dsDNA is likely to be due to the
opportune transient binding of two monomers in close
proximity on the DNA helix, allowing residual
cross-domain interactions to form and hold the protein
in a dimeric conformation. Evidently, ssDNA cannot
promote dimerization in this manner. This highlights the
role that interactions between the DNA duplex and the
residues lining the inside surface of the ring can have on
dimer stability. These results also demonstrate that the
monomeric state of RdgC cannot stably bind to small
oligonucleotides, particularly with ssDNA. If the
complexes observed with wild-type RdgC at low protein
concentration were with a monomeric species, then we
would expect equivalent complexes with the F120T
K227A mutant. From this, we conclude that the primary
complexes observed must be between the dimeric protein
and the oligonucleotide, and the higher order complexes
seen at higher protein concentrations are likely to be due
to the subsequent addition of RdgC dimers.
RdgC modiﬁcations appear to have no eﬀect on
plasmid binding
The in vitro oligonucleotide binding studies are broadly in
agreement with the in vivo synthetic lethality studies, but
they do not tell the whole story. All mutations had a
negative eﬀect on viability, even when little or no eﬀect
on oligonucleotide binding was seen. Does this reﬂect the
use of small oligonucleotides rather than a large circular
DNA molecule corresponding to a chromosome? It is
possible that an RdgC dimer does not have to open and
close its ring structure to bind to an oligonucleotide;
rather it can simply slide on from the end. In order to
determine the eﬀects of domain boundary mutations on
the binding of molecules when the opening and closing is
essential, we looked at the binding of RdgC to a circular
DNA molecule.
Band-shift studies with native RdgC and the circular
plasmid, pGEM-7 Zf(+), conﬁrmed that RdgC can load
onto and bind circular DNA (Figure 4E). However, the
results with the single mutation proteins, and the R118C
F120T double mutant, were largely indistinguishable from
those with native protein and all appeared to be able to
load onto and bind circular DNA with the same aﬃnity as
the native protein. In all cases, binding could be observed
with 100–200nM RdgC (dimer) and 2.2nM plasmid DNA
(equivalent to  300nM RdgC binding sites). This was
completely unexpected and is in variance with both the
in vivo viability data and the oligonucleotide binding
data. In contrast, plasmid binding by the F120T K227A
double mutant was at least an order of magnitude weaker
(Figure 4F). Importantly, this implies there is a speciﬁc
requirement for RdgC to be in a dimeric form before it
can eﬃciently bind circular DNA. An explanation for the
diﬀerence between the plasmid and oligonucleotide
binding observed is that the mutant proteins can load
onto DNA, but do not bind tightly once they are
loaded. If the DNA is in the form of a short oligonucleo-
tide, then the protein simply slides along the DNA and
falls oﬀ the end. This would also explain the smearing seen
in the band-shift assays (Figure 4A), which is indicative of
complex dissociation. When the DNA is circular, then the
loaded mutant RdgC can slide along the DNA molecule
without falling oﬀ and so the complex, as observed by the
band-shift assay, remains intact. However, this complex is
not functional, as demonstrated by our synthetic lethality
assays. For RdgC to function, it is not enough to be
simply associated with the DNA: there is a speciﬁc re-
quirement for a tight-binding complex. This has implica-
tions for its mode of activity, and provides insight into
how RdgC modulates RecA-mediated homologous
recombination.
The role of the ﬁnger domain
We have previously speculated on how RdgC may load
onto circular DNA, and proposed that this was a property
of the electropositive ﬁnger domain (21). We investigated
the role of the ﬁnger domain by constructing two mutant
proteins. The ﬁrst construct, named the ﬁngertip
mutation, had all four highly conserved basic residues
located at the end of the ﬁnger (Figure 6A) mutated to
R97S, K98Q, K100Q and K101E. The second construct
had a deletion of residues 77–115, and substitutions of
P76G and L116T to allow the formation of a type II’
b-hairpin turn. This ﬁnger construct removes the
whole of the ﬁnger domain, while allowing the rest of
the protein to fold correctly. In addition, this construct
retains the R118 and F120 residues at the gate interface,
although it may disrupt some of the hydrophobic bind-
ing pocket. To overcome this, we also made a ﬁnger
construct which incorporated the R118C mutation,
as we postulated that any loss of dimer interface stabil-
ity caused by disruption of the hydrophobic
pocket may be overcome by the addition of a disulphide
bond.
When the chromosomal copy of rdgC was replaced with
our ﬁnger-mutation versions of rdgC in the synthetic le-
thality assay, we saw that the ﬁnger derivative of RdgC
gave only blue colonies in the priA
+/priA background on
LB agar and MA and in the priA
+/priA dnaC810 back-
ground on LB agar (Figure 6B and data not shown). This
indicates that the ﬁnger protein is functionally inactive.
Nucleic Acids Research, 2010,Vol.38, No. 19 6441The addition of the R118C mutation appeared to have no
eﬀect, as this also gave only blue colonies. The ﬁngertip
derivative also gave only large blue colonies in a priA
+/
priA background on both LB agar and MA, but a few
small white colonies were observed in a priA
+/priA
dnaC810 background on LB agar (Figure 6B), suggesting
some functionality had been retained. Taken together,
these data suggest that the ﬁnger domain is critical to
the in vivo role of RdgC.
We puriﬁed the three proteins, and found that they
behaved identically to the native protein throughout the
puriﬁcation, although the ﬁnger constructs eluted
slightly later from the gel ﬁltration column with an
estimated molecular weight of 45kDa. As this construct
contained a deletion of 39 residues and had a calculated
molecular weight of 28.8kDa, this was consistent with the
aberrant elution proﬁle of the full-length native protein.
After incubation of the puriﬁed proteins in gel ﬁltration
buﬀer (50mM Tris, pH 7.5, 100mM NaCl), analytical gel
ﬁltration of the ﬁnger protein showed the emergence of a
secondary peak with an estimated MW of 90kDa, while
the ﬁnger R118C construct displayed a DTT-sensitive
peak of the same size, indicative of disulphide-bound
oligomers (Figure 3D). CD analysis suggested the
mutant proteins contained similar proportions of second-
ary structure to the native protein (data not shown), sug-
gesting that they had folded correctly.
Band-shift assays using the small double-stranded and
single-stranded oligonucleotides (Figure 6C and D)
indicated that the ﬁnger construct was completely
unable to stably bind to either oligonucleotide, and the
data were such that it was impossible to calculate a
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Figure 6. Properties of the ﬁnger domain. (A) Electrostatic surface representation of a ﬁnger domain, illustrating its electropositive nature and the
position of the four conserved basic residues modiﬁed in the RdgCﬁngertip derivative. (B) Synthetic lethality assays showing the eﬀect of ﬁnger domain
mutations on priA dnaC810 strain viability. Colonies were grown on LB agar. (C) Quantiﬁcation of dsDNA binding. Reactions used the RdgC
proteins indicated and
32P-labelled RGL13/17 DNA at 0.2nM. Data are means of at least two band-shift assays. (D) Quantiﬁcation of ssDNA
binding. Reactions used the RdgC proteins indicated and
32P-labelled RGL13 DNA at 0.2nM. Data are means of at least two band-shift assays. (E)
Plasmid binding. Reactions used the RdgC proteins indicated at 0, 34, 68, 136, 272, 544, 1088, 2176 and 23400nM (of dimer) and pGEM-7 Zf(+)
DNA at 2.2nM plasmid.
6442 Nucleic Acids Research, 2010,Vol.38, No. 19value for the Kd. Some formation of complex was
observed with a 5000-fold excess of protein, but the
smearing seen is indicative of this complex falling apart
during electrophoresis. In contrast, both the ﬁnger
R118C protein and the ﬁngertip protein showed some
binding to both ssDNA and dsDNA, with the formation
of a stable complex with dsDNA at very high concentra-
tions of protein. This was diﬀerent to the dsDNA binding
seen with several of the dimer interface mutations where,
even though the complex could form, it was less stable and
appeared to dissociate readily. Further analysis of dsDNA
binding by the ﬁnger R118C and the ﬁngertip proteins,
using an extended protein concentration, gave a sigmoid
binding curve reminiscent of that seen with the native
protein, though with a much reduced aﬃnity. The
calculated Kd values for the ﬁngertip protein with
dsDNA and ssDNA were 170nM and 240nM, respective-
ly, whereas those for ﬁnger R118C were 80nM with
dsDNA and  6000nM with ssDNA. The large diﬀerence
between the activities of the ﬁnger and the ﬁnger
R118C proteins would suggest that the engineered
R118C disulphide observed by analytical gel ﬁltration sta-
bilizes the dimer interface. It is possible that the formation
of the disulphide is enhanced by dsDNA binding, where
the interactions around the RdgC central pore pulls the
domains together into a conformation conducive to disul-
phide bond formation. This may explain the large diﬀer-
ence in aﬃnities of the ﬁnger R118C protein for dsDNA
over ssDNA. This would also suggest that the gate inter-
face is compromised by the deletion of the ﬁnger region,
such that the F120-mediated interaction is destabilized,
which is not surprising as some of the residues forming
the hydrophobic binding pocket are at the base of the
ﬁnger domain.
These data provide insight into the role of the ﬁnger
domain. It appears to be involved in the initial DNA
binding, but to be less important in the stability of the
complex once it is formed. This agrees with our hypothesis
that the main function of the ﬁnger domain is the loading
of RdgC onto the DNA. If this is true, we would expect to
see a marked diﬀerence in the ability of the ﬁnger mutants
to bind to circular DNA molecules, where loading is es-
sential. Band-shift assays with the ﬁnger mutants and
pGEM-7 Zf(+) conﬁrmed that this was the case
(Figure 6E). In stark contrast to the domain boundary
mutants, which were indistinguishable from native
RdgC, each of our ﬁnger mutants were severely
compromised for plasmid binding. We saw no complex
formation with the ﬁnger protein, even when the
protein concentration was increased 100-fold over that
required to show a complete shift. For native RdgC,
some binding was observed with the other two mutants
at these very high concentrations, but the degree of
band-shift when compared to the results from the native
protein was indicative that very few RdgC molecules had
actually bound. This conﬁrms that the ﬁnger domain, and
speciﬁcally the basic nature of the ﬁnger, is essential
for the eﬃcient loading of RdgC onto circular DNA
and by extrapolation, the binding of the bacterial
chromosome.
DISCUSSION
The crystal structures of RdgC from E. coli (21) and
P. aeruginosa (22) showed it to form a ring that was
proposed to encircle the DNA, so stabilizing the DNA
to unwinding. However, this left unanswered the
question of how this ring could be loaded onto a
circular DNA molecule. Does RdgC assemble on the
DNA, with sequential binding by monomers, or does the
ring open at one or both of the domain interfaces,
allowing it to slip over the DNA duplex? To investigate
this, we studied the eﬀect of destabilizing the domain
boundaries using site-directed mutagenesis and a combin-
ation of genetic and biochemical assays.
Our initial discovery that native RdgC puriﬁed as a
monomer, rather than a dimer as reported previously
(3,4), was surprising. However, the previous reports are
from before the structure was known, and the
non-globular nature of RdgC would account for the
anomalous migration on gel ﬁltration which had been
used to determine the oligomeric state. This does not
inform us about the in vivo state of E. coli RdgC, as we
have shown that incubation in a high ionic strength buﬀer
causes the protein to monomerize, and such a step is
reported in all previous puriﬁcation protocols. Ha et al.
(22) report that RdgC from P. aeruginosa puriﬁes as a
dimer, although data to demonstrate this is not shown,
and their puriﬁcation procedure also contains highly
ionic step. However, it is worth noting that RdgC from
both E. coli and P. aeruginosa crystallized as a dimer in the
absence of an oligonucleotide. Indeed, Drees et al. (5)
suggest that RdgC is in equilibrium between monomer–
dimer–trimer states in solution, although they also suggest
a monomer–dimer–tetramer model would ﬁt their data.
Subsequent knowledge of the crystal structure suggests
the second model is more likely.
Our experiments demonstrate that weakening either the
gate or the horseshoe interface by removing potential
residue-mediated interactions has a severe eﬀect on the
binding of small DNA oligonucleotides. This adds
weight to our assumption that the DNA must go
through the central pore, as a weakened dimer interface
would only eﬀect binding if the DNA was encircled.
Interestingly, these modiﬁcations appeared to have no
eﬀect on the ability of RdgC to bind to circular plasmid
DNA. We propose that a tight-binding complex does not
form, and the modiﬁed RdgC is sliding along the DNA
without dissociating. This is consistent with gel ﬁltration
data showing that the mutant proteins can still form stable
dimers in solution. Presumably, even with weakened
domain interfaces, RdgC can adopt an open or closed
conformation, both of which would stay associated with
a circular molecule. However, the loss of in vivo activity
observed in our synthetic lethality assays suggests that
remaining associated with DNA is not suﬃcient for
function: RdgC is only functional when it is bound
tightly to the DNA.
We have also shown that the loading of RdgC onto
circular DNA can be attributed to the ﬁnger domain, as
modiﬁcation or deletion of this domain eliminated
plasmid binding. It is possible that the deletion of the
Nucleic Acids Research, 2010,Vol.38, No. 19 6443entire ﬁnger domain (76–115) also disrupts the hydro-
phobic F120-binding pocket, but this would not be
enough to explain the complete lack of plasmid binding
observed, as the F120S and F120T proteins were seen to
load normally. That the ‘loading’ activity is largely due to
the electropositive nature of the ﬁnger domain was con-
ﬁrmed by the observed eﬀect of substituting the basic
residues at the ﬁngertip. Additionally, the electropositive
nature of the ﬁnger domain seems to be involved in the
initial recognition and binding of the DNA molecule by
RdgC, as mutations appear to aﬀect the ability to form the
protein-DNA complex, but contribute little to the stability
of this complex once it has formed. Analysis of the F120T
K227A double mutant, which retains the native electro-
positive ﬁnger, supports this, as it is incredibly poor at
binding any of the three DNA substrates assayed. If the
ﬁnger contributed signiﬁcantly to the stability of the
RdgC–DNA complex, then the F120T K227A monomer
would be expected to bind to DNA. As it is, we see no
evidence of the monomer forming a stable complex with
the DNA.
These results, coupled with the crystal structures,
provide compelling evidence that RdgC is bound to
DNA as a dimer, but doesn’t address the mechanism of
how RdgC binds to DNA. It is possible that the RdgC
monomers bind sequentially, with the dimer assembling
on the DNA. However, if this was the case, then we
would expect to see some binding by the RdgC
monomer. In addition, it would be diﬃcult to explain
why mutating the ﬁngertip residues has such a dramatic
eﬀect on DNA binding activity, as the electropositive
residues on the inside of the ring would be accessible to
the DNA and the residues required for dimerization are
intact. In contrast, if RdgC is a dimer in solution, such
that the ring is already closed, then the electropositive
residues inside the ring are not accessible for DNA
binding, and an additional solvent-accessible structure is
necessary for the initial location and interaction with the
DNA. We suggest the ﬁnger domain forms this
solvent-accessible structure and we propose a model for
how this could facilitate DNA binding by the RdgC dimer
in vivo.
The ﬁrst step involves RdgC locating the DNA by
means of the electropositive ﬁnger domain, which is
solvent exposed and accessible. The DNA then binds
across the surface of the ﬁnger domain and across the
face of the RdgC ring (Figure 7A). This causes a conform-
ational rotation in the ﬁnger domain, which in turn
disrupts the F120-mediated interaction at the gate inter-
face (Figure 7B). Disruption of the interface allows the
gate to open, ﬂexing at the linker region between the
gate and horseshoe domains (residues S160 to N170),
and the RdgC slides over the DNA (Figure 7C). Once
the DNA is properly located in the central binding
channel, the electropositive residues lining the channel
pull the dimer together. The ﬁnger domain returns to its
original conformation and lies parallel to the bound DNA
duplex, allowing the gate to close; such that the ring struc-
ture is reformed (Figure 7D). This leaves RdgC clamped
tightly around the DNA, stabilizing the encircled duplex
to unwinding.
A
C
B
D
Figure 7. Model illustrating how RdgC may load onto DNA. (A)
DNA binds across an exposed positive face, interacting with the
ﬁnger domain. (B) The ﬁnger domain rotates, disrupting the gate
dimer interface. (C) The gate opens, and RdgC slides over the DNA.
(D) The gate closes, encircling the DNA within the ring.
6444 Nucleic Acids Research, 2010,Vol.38, No. 19Such a tight-binding complex could readily block RecA
mediated strand exchange. If RdgC is bound near the site
of a double-strand break, it would inhibit RecA ﬁlament
assembly by preventing extension of the ﬁlament from the
ssDNA region into the duplex. Alternatively, if bound
near a potential site of recombination, RdgC would
either restrict the unwinding of the duplex required for
strand invasion, or would limit branch migration and so
the completion of strand exchange.
This model does highlight a potential problem: if RdgC
can bind so tightly to DNA that it can eﬃciently block
RecA activity, then why doesn’t it aﬀect other processes
that require DNA strand separation like replication and
transcription? It is possible that this is another important
role for the ﬁnger domain. As the ﬁnger domains project
perpendicular to the ring, they will lie along the length of,
and parallel to, the encircled DNA strand. This would
mean that any protein translocating along the DNA, e.g.
a helicase or polymerase, would make an initial protein–
protein interaction with the ﬁnger domain. This could
then induce a conformational shift in the ﬁnger domain
similar to that proposed on DNA loading, causing the
gate to open, and allowing the translocating protein to
eﬃciently displace RdgC from the DNA duplex.
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